CSF tau and Aβ42: Logical biomarkers for Alzheimer's disease?

Neurobiology of Aging

Volumn 19, Issue 2, 1998, Pages 117-119

  Galasko, D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; TAU PROTEIN;

ACCURACY; ALZHEIMER DISEASE; CALIBRATION; CEREBROSPINAL FLUID; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SENILE PLAQUE; TECHNIQUE; ARTICLE; DIFFERENTIAL DIAGNOSIS; PATHOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; HUMANS; TAU PROTEINS;

EID: 0032008572     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(98)00021-9     Document Type: Conference Paper

References (21)

1. 1. Arai, H.; Terajima, M.; Miura, M., et al. Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease. Ann. Neurol. 38:649-652; 1995.
2. 2. Blennow, K.; Wallin, A.; Agren, H.; Spenger, C.; Siegfried, J.; Vanmechelen, E. Tau protein in cerebrospinal fluid. A biochemical marker for axonal degeneration in Alzheimer disease? Mol. Chem. Neuropathol. 26:231-245; 1995.
3. 3. Galasko, D.; Clark, C.; Chang, L., et al. Assessment of cerebrospinal fluid levels of tau in mildly demented patients with Alzheimer's disease. Neurology 48:632-635; 1997.
4. 4. Galasko, D.; Hansen, L. A.; Katzman, R., et al. Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Arch. Neurol. 51:888-895; 1994.
5. 5. Gearing, M.; Olson, D. A.; Watts, R. L.; Mirra, S. S. Progressive supranuclear palsy: neuropathologic and clinical heterogeneity. Neurology 44:1015-1024; 1994.
6. 6. Hulette, C.; Nochlin, D.; McKeel, D., et al. Clinical-neuropathologic findings in multi-infarct dementia: a report of six autopsied cases. Neurology 48:668-672; 1997.
7. 7. Ida, N.; Hartman, T.; Pantel, J., et al. Analysis of heterogeneous βA4 peptides in human cerebrospinal fluid by a newly developed sensitive Western blot assay. J. Biol. Chem. 271:22908-22914; 1996.
8. 8. Jensen, M.; Basun, H.; Lannfelt, L. Increased cerebrospinal fluid tau in patients with Alzheimer's disease. Neurosci. Lett. 186:189-191; 1995.
9. 9. Johnson, G. V.; Seubert, P.; Cox, T. M.; Motter, R.; Brown, J. P.; Galasko, D. The tau protein in human cerebrospinal fluid is Alzheimer's disease consists of proteolytically derived fragments. J. Neurochem. 68:430-433; 1997.
10. 10. Klatka, L. A.; Schiffer, R. B.; Powers, J. M.; Kazee, A. M. Incorrect diagnosis of Alzheimer's Disease. A clinicopathologic study. Arch. Neurol. 53:35-42; 1996.
11. 11. McKeith, I. G.; Galasko, D.; Kosaka, K., et al. Consensus criteria for the clinical and pathological diagnosis of dementia with Lewy bodies. Neurology 47:1113-1124; 1996.
12. 12. Morris, J. C.; McKeel, J. W.; Fulling, K.; Torack, R. M.; Berg, L. Validation of clinical diagnostic criteria for Alzheimer's disease. Ann. Neurol. 24:17-22; 1988.
13. 13. Mori, H.; Hosoda, K.; Matsubara, E. Tau in cerebrospinal fluids: establishment of the sandwich ELISA with antibody specific to the repeat sequence in tau. Neurosci. Lett. 186:181-183; 1995.
14. 42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann. Neurol. 38:643-648; 1995.
15. 15. Reid, M. C.; Lachs, M. S.; Feinstein, A. R. Use of methodological standards in diagnostic test research. Getting better but still not good. JAMA 274:645-651; 1995.
16. 16. Riemenschneider, N. M.; Buch, K.; Schmolke, M.; Kurz, A.; Guder, W. G. Cerebrospinal fluid tau is elevated in early Alzheimer's disease. Neurosci. Lett. 212:209-211; 1996.
17. 17. Rosler, N.; Wichart, I.; Jellinger, K. A. Total tau protein immunoreactivity in lumbar cerebrospinal fluid of patients with Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 60:237-238; 1996.
18. 18. Tamaoka, A.; Sawamura, N.; Fukushima, T., et al. Amyloid beta protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease. J. Neurol. Sci. 148:41-45; 1997.
19. 19. Tierney, M. C.; Fisher, R. H.; Lewin, A. J., et al. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease. Neurology 38:359-369; 1989.
20. 20. Vandermeeren, M.; Mercken, M.; Vanmechelen, E. Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. J. Neurochemistry 61:1828-1834; 1993.
21. 21. Vigo-Pelfrey, C.; Seubert, P.; Barbour, R., et al. Elevation of microtubule-associated protein tau in the cerebrospinal fluid of Alzheimer's patients. Neurology 45:788-793; 1995.